Abstract
This paper evaluated 3-dimensional radiomics features of breast magnetic resonance imaging (MRI) as prognostic factors for predicting systemic recurrence in triple-negative breast cancer (TNBC) and validated the results with a different MRI scanner. The Rad score was generated from 3-dimensional radiomic features of MRI for 231 TNBCs (training set (GE scanner), n = 182; validation set (Philips scanner), n = 49). The Clinical and Rad models to predict systemic recurrence were built up and the models were externally validated. In the training set, the Rad score was significantly higher in the group with systemic recurrence (median, −8.430) than the group without (median, −9.873, P < 0.001). The C-index of the Rad model to predict systemic recurrence in the training set was 0.97, which was significantly higher than in the Clinical model (0.879; P = 0.009). When the models were externally validated, the C-index of the Rad model was 0.848, lower than the 0.939 of the Clinical model, although the difference was not statistically significant (P = 0.100). The Rad model for predicting systemic recurrence in TNBC showed a significantly higher C-index than the Clinical model. However, external validation with a different MRI scanner did not show the Rad model to be superior over the Clinical model.
Highlights
This paper evaluated 3-dimensional radiomics features of breast magnetic resonance imaging (MRI) as prognostic factors for predicting systemic recurrence in triple-negative breast cancer (TNBC) and validated the results with a different MRI scanner
We tried to build up a model to predict systemic recurrence in TNBCs using the 3-dimensional radiomics features of pretreatment breast MRI
When the Rad score was combined with clinicopathologic variables, the new model was able to predict systemic recurrence better than the model comprised only with clinicopathologic variables
Summary
This paper evaluated 3-dimensional radiomics features of breast magnetic resonance imaging (MRI) as prognostic factors for predicting systemic recurrence in triple-negative breast cancer (TNBC) and validated the results with a different MRI scanner. The C-index of the Rad model to predict systemic recurrence in the training set was 0.97, which was significantly higher than in the Clinical model (0.879; P = 0.009). The Rad model for predicting systemic recurrence in TNBC showed a significantly higher C-index than the Clinical model. External validation with a different MRI scanner did not show the Rad model to be superior over the Clinical model. The purpose of our study was to evaluate 3-dimensional radiomics features of breast MRI as prognostic factors for predicting systemic recurrence in TNBC. The results were externally validated with a different MRI scanner
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have